In an effort to develop a guiding and monitoring tool for transmyocardial gene transfer, we have evaluated the feasibility of intracardiac echocardiography (ICE) to guide percutaneous endomyocardial gene transfer (PEGT), and monitor complications, in a pig model. ICE (5.5-10 MHz), complemented by fluoroscopy, was utilized to guide a needle injection into the heart in 19 normal pigs. Using this system, we injected Evans blue dye into eight pigs (group I), a mixture of pCK-CAT plasmid and India ink into seven pigs (group II), and pCK-LacZ plasmid into four pigs (group III). In all pigs, ICE contributed to the injection procedure by guiding the catheter to anatomically distinct sites, and by assisting stabilization of the catheter-endocardial contact. ICE predicted the injection sites correctly in 56 of 64 sites (87.5%) in group I, and in 42 of 42 sites (100%) in group II. Leakage of injectate into the left ventricular cavity could be detected by the microbubbles generated. The sites of injections appeared as foci of bright myocardial echodensity, which persisted until the end of the procedure. The procedures were not associated with significant morbidity or mortality. The expression of the chloramphenicol acetyltransferase (CAT) gene was identified in 40 sites from 42 injections (95.2%) in group II. In group III, histology showed positive b -galactosidase staining of myocytes limited around the needle track with low transfection efficiency (,1%). These results suggest that real-time ICE monitoring proves safe and useful during PEGT for guiding needle injection, monitoring leakage, ensuring delivery of injectate into the myocardium, and instantly diagnosing cardiac complications, resulting in successful gene transfer.
INTRODUCTION T
HERAPEUTIC ANGIOGENES IS, with direct gene transfer, is a novel strategy for the treatment of patients with chronic angina not amenable to conventional therapy (Losordo et al., 1998; Rosengart et al., 1999) . The effect of direct myocardial angiogenic gene transfer via an open thoracotomy has been reported (Losordo et al., 1998; Rosengart et al., 1999; Symes et al., 1999) . However, the development of a less invasive method is necessary for the delivery of angiogenic substances. The feasibility of fluoroscopy-guided, or electromechanical mapping, catheter-based intramyocardial injection of marker genes or therapeutic genes has been demonstrated in animal models Kornowski et al., 2000; Sanborn et al., 2000; Gwon et al., 2001) . However, these methods may need a complementary guiding tool for monitoring leakage of the injectate, for ensuring gene delivery, and for monitoring complications such as changes in regional wall motion and development of pericardial effusion.
Echocardiography could provide improved imaging of cardiac structures, and suitable catheter guidance, in real time. Therefore, it may be an effective tool to complement other guidance systems. The usefulness of transesophageal echocardiography (TEE) in intraoperative myocardial gene transfer has been reported . However, when prolonged TEE imaging is required for cardiovascular interventions in conscious patients, increased patient discomfort, the need for sedation, and the administration of a general anesthetic are additional issues that require consideration. A steerable multiple-frequency intracardiac echocardiography (ICE) transducer has been developed (Bruce et al., 1999) . Its diameter is small enough that the transducer may be inserted into the right heart intravenously, using a percutaneous technique. The value of ICE could derive from the relative ease of imaging in the midst of other ongoing procedures, the detailed nature of the images, and the relative safety of the procedure.
In this study, ICE was investigated as a monitoring tool, to facilitate percutaneous endomyocardial gene transfer (PEGT). The purposes of this study were (1) to assess the value of ICE as a tool for guiding needle injection into the left ventricular myocardium, and monitoring complications during the procedure, and (2) to study the efficiency of gene transfer into the myocardium, using our method.
MATERIALS AND METHODS

Plasmids
We had constructed plasmids of pCN and pCK, as reported previously . pCN has a backbone of pCDNA3.1 from InVitrogen (Carlsbad, CA). Both pCN and pCK are transcriptionally regulated by the cytomegalovirus promoter/enhancer. They contain not only the full-length immediate-early (IE) promoter of human cytomegalovirus (HCMV) but also its entire 59 untranslated region upstream from the start codon of the IE gene. pCK was modified from pCN. In pCK, the b-lactamase gene was replaced with the kanamycin resistance gene and all possible nucleotide sequences unnecessary for a vector to function as a gene delivery vehicle were removed to produce a final size of 3.7 kb. The pCK-CAT plasmid encodes the chloramphenicol acetyltransferase (CAT) gene. pCN-LacZ encodes the b-galactosidase gene. In our previous report, both pCN and pCK were able to drive high levels of gene expression in the skeletal muscles of mice . 
Intracardiac echocardiography
The transducer for ICE (AcuNav; Acuson, Mountain View, CA) is a longitudinal side-fire transducer (5.5-10 MHz), with a 3.2-mm (10F) diameter, and a phased vector array imaging format (Fig. 1A) . It can be steered through two planes and four directions, that is, anterior/posterior and left/right. Its curve radius is 65 mm, and its maximal deflection is 160 degrees, with a 90-degree knob rotation (Fig. 1B) . The ICE catheter was connected to an echocardiography console (Sequoia C256; Acuson). It was inserted through the left internal jugular vein, and positioned in the right heart. Complete baseline diagnostic studies were performed initially, including two-dimensional examination of the cardiac chambers and valves, and color flow Doppler evaluation of valves. The steerability of this device, coupled with its ability to rotate, allowed access to multiple imaging planes. All studies were stored on magneto-optical disc and super VHS videotape. In most cases, 8.5-MHz frequency was used to optimize the image of the left ventricle. Continuous monitoring with ICE was performed during the whole PEGT procedure.
Animal preparation
Nineteen female domestic pigs, each weighing 25-40 kg, were studied with three protocols. All pigs received humane care in compliance with the Guide for the Care and Use of Laboratory Animals prepared by the National Institutes of Health (NIH Publication No. 85-23, revised 1996) . Aspirin (300 mg) was given orally 1 day before the PEGT procedure. Animals were sedated by an intramuscular injection of xylazine (2 mg/kg), ketamine (20 mg/kg), and atropine (0.05 mg/kg), followed by intravenous thiopental sodium (10 mg/kg). All animals received inhalation ventilation with 2% enflurane, and supplemental oxygen at 3 L/min. Blood pressure, heart rate, and electrocardiography (ECG) were monitored continuously. An 8F arterial sheath was inserted into the left common carotid artery for the introduction of the needle injection catheter, and an 11F arterial sheath was inserted into the left internal jugular vein for the ICE transducer. After heparin (200 U/kg) was given intravenously, the ICE transducer was inserted into the right heart, under single-plane fluoroscopic guidance (TH9428; Sias, Italy), and the needle injection catheter was inserted into the left ventricle under the guidance of both ICE and fluoroscopy. After the transendomyocardial injection procedure, the arterial and venous puncture sites were closed, and the animals in protocol I were killed immediately. In protocols II and III, animals were given intramuscular enrofloxacin (0.05 mg/kg), and killed 7 and 4 days later, respectively.
Transendomyocardial injection
The needle injection catheter (Biosense Webster, Diamond Bar, CA) is a modified 8F mapping catheter. Its distal tip incorporates a 27-gauge needle that can be protruded 3-5 mm by remote control (Fig. 1C) . It was inserted into the left ventricle and manipulated to make a stable contact with the endocardium, which was targeted under the guidance of ICE. Single-plane fluoroscopy was also used for injection catheter positioning (Fig. 1D ). For evaluation of the intracavitary leakage of the injectate, two injections of 1.0 ml of normal saline in each pig were performed when the needle injection catheters contacted the endocardium, without needle protrusion. Once a target site was fixed, the needle was advanced 3-4 mm into the endomyocardium, and 0.2 ml of sterile saline or 150 mM sodium phosphate solution was test injected. After the ICE showed no leakage of injected saline solution into the left ventricular cavity, 1.0 ml of injectate (Evans blue dye in protocol I, a mixture of plasmid DNA and India ink in protocol II, plasmid DNA with or without fluorescent microspheres in protocol III) was delivered, and followed by injection of 0.2 ml of sterile saline or
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FIG. 2.
Schematic division of the porcine left ventricle into 11 segments to locate the injection site. Anatomical logic and internal anatomical landmarks for easy identification of the segment were considered. The basal portion extended from the mitral annulus to the superior insertion site of both papillary muscles. The apical wall extended from the inferior insertion site of both papillary muscles to the apex, and the midportion extended from the basal portion to the apical wall. For longitudinal division of basal and midportions, the lateral wall (Lat) involved the anterior papillary muscle (APM); the inferior wall (Inf) involved the posterior papillary muscle (PPM). The anterior and posterior walls were defined as those between the septum and lateral wall, and between the lateral and inferior walls, respectively. Ao, Aorta; Ant, anterior wall; Post, posterior wall.
FIG. 3. (A)
A longitudinal image of the left ventricle scanned by ICE from the right ventricle. This image is similar to a parasternal long-axis view in transthoracic echocardiographic examination. An ICE transducer with high frequency provided high-resolution images of fine structures in both the far field and the near field, which covered the entire left ventrice. LA, Left atrium; LV, left ventricle; AO, aorta. (B) ICE image of the needle injection catheter in the left ventricle. ICE visualized the injection catheter, but the needle protruding from its tip could not be seen. The distal electrode of a magnetic electrode catheter was easily visible as a highly refractile structure (arrow) with reverberations (arrowheads). (C) Intracardiac echocardiographic findings of intracavity leakage of the injectate. ICE showed intracavity microbubbles (arrowheads) when the injectate was introduced while the needle injection catheter was in contact with the endocardium, without needle protrusion. (D) Myocardial echo enhancement after endomyocardial injection. Myocardial echo was enhanced (solid arrows) at the injection site, and enhancement persisted while another site was targeted by the needle injection catheter (open arrowhead). Myocardial echo enhancement after injection persisted for at least 20 min, the total time required for completion of all endomyocardial injections at eight sites per pig. LA, Left atrium; LV, left ventricle; AO, aorta.
A B
150 mM sodium phosphate, for flushing the catheter. After the completion of the injection, the needle was withdrawn, and the catheter was moved to the next injection site.
Protocol I: Localization study
Eight healthy pigs received eight injections of 1 ml of Evans blue dye per pig. The heart was divided into 11 segments across 6 walls, to locate the injection site (Fig. 2) . Eight of 11 segments were injected in each animal. For one injection per animal, the volume of injectate was increased from 0.5 to 2.0 ml, in 0.5-ml increments, in the same injection site, to evaluate the change in myocardial echodensity induced by the injectate.
After the eighth injection, the animal was killed, and the heart was exposed by median sternotomy. The pericardial sac was examined for pericardial effusion, cardiac muscle rupture, and pericardial hematoma. The heart was then rapidly excised and placed in ice-cold saline. After examining both atria and the
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FIG. 3. Continued.
C D right ventricle, they were removed. The left ventricle was then opened by longitudinal incision along the anterior interventricular groove, and examined to evaluate its gross appearance (i.e., mural thrombus or other injuries), and to locate injection sites stained with Evans blue dye. The dye-stained cross-sectional surfaces of the injection sites were also inspected for intramural hematomas. We compared the injection sites indicated prospectively in vivo on the endocardial map, by ICE, with those of Evans blue staining identified in each heart at the postmortem examination.
Protocol II: CAT gene expression study
Each of seven healthy pigs received six injections of a 1.0-ml mixture of India ink and 100 mg of pCK-CAT plasmid DNA in normal saline. Each injection was assigned to one of six walls. All the animals were killed 7 days after the gene injection, and visually inspected as in protocol I. Injection sites were identified by India ink staining, and excised as round, 14-mm-diameter transmural blocks (0.90 to 1.72 g) of myocardium. For analysis of control sites, a total of 14 normal myocardial blocks, remote from India ink staining, were obtained in the same way. The excised myocardial block was carefully examined for the presence of intramural hematoma. It was immediately preserved in 2.0 ml of homogenization buffer and then homogenized and centrifuged at 6000 3 g for 10 min at 4°C, and the supernatant was recovered. Levels of CAT protein were measured with a commercially available enzyme-linked immunosorbent assay (ELISA) kit (Boehringer Mannheim, Indianapolis, IN). Results were expressed as mean picograms of CAT per gram wet tissue 6 SEM.
Protocol III: b-Galactosidase gene expression study
Each of four pigs received six injections of a 1.0-ml mixture of 100 mg of pCN-LacZ plasmid in 150 mM sodium phosphate solution. After harvesting the treated tissue 4 days after injection, the left ventricle was divided into two longitudinal segments and sliced at 3-to 5-mm thickness from the apex to the base of the heart. To localize precisely the sites of injection, we used two techniques. In two hearts, sliced specimens were subject to fixing (in 4% paraformaldehyde solution-phosphatebuffered saline [PBS] for 60 min at 4°C), and subsequently processed for 5-bromo-4-chloro-3-indolyl-b-D-galactopyranoside (X-Gal) staining. The X-Gal-stained area was then excised, cryoprotected (in 30% sucrose-PBS overnight at 4°C), and cryosectioned in O.C.T. medium. In another two hearts, fluorescent microspheres (Flouresbright; Polysciences, Warrington, PA) were mixed with DNA in a 1:20 dilution and injected into the myocardium. This method allows for precise localization of the site of injection when inspected for fluorescence with an ultraviolet lamp (Kornowski et al., 2000) . The fluorescent area was excised and subsequently processed for fixing, cryoprotection, cryosection, and X-Gal staining. For X-Gal staining, the following procedure was employed: the sample was washed in PBS containing 2 mM MgCl 2 , 0.01% sodium deoxycholate, and 0.5% Nonidet P-40 (NP-40). The sliced heart or sectioned slide was then incubated overnight or for 1 hr, respectively, at 37°C in PBS containing 2 mM MgCl 2 , 0.01% sodium deoxycholate, 0.4% NP-40, 4 mM potassium ferricyanide, 4 mM potassium ferrocyanide, and X-Gal (1 mg/ml). The pH values of all solutions were kept above 7.4. The 10-mm serial sections were counterstained with hematoxylin and eosin (H&E) for visualization of the cells.
Statistics
For comparison of variables, on unpaired Student t test or repeated measures analysis of variance (ANOVA) was used, as appropriate. Statistical significance was defined as p , 0.05.
RESULTS
Basal ICE study
Complete ICE examination was possible in all 19 pigs. There were no difficulties in ICE catheter passage into the right atrium or right ventricle, under fluoroscopy. There were no complications of the ICE procedure in any of the pigs. The tomographic image presentation allowed long-and short-axis views of cardiac structures. Clearly, a learning experience was present for the appropriate handling and manipulation of the device. The best images of left ventricular structures were invariably taken from the right ventricular cavity, as opposed to the right atrium. The ICE transducer provided excellent images with high resolution of fine structures, in both the far field and the near field, which covered the entire left ventricle (Fig. 3A) . However, because the apex of the left ventricle is deeper than that of the right ventricle, ICE with a side-fire transducer scanning from the right ventricular apex could not provide optimal images of the left ventricular apex, in some cases. Left ventricular wall motion could be qualitatively assessed. Minimal aortic regurgitation was noted by color Doppler examination, after the injection catheter was introduced into the left ventricle.
ICE guidance of injection
ICE guidance for endomyocardial injection was possible in all 19 pigs. ICE could visualize the injection catheter, but the needle, protruded from the tip of catheter, could not be seen. The distal electrode of a magnetic electrode catheter was easily visible as a highly refractile structure (Fig. 3B ). The catheter tip was easier to visualize in the longitudinal plane than in the orthogonal plane. Therefore, ICE was useful to assess the stability of catheter-endocardial contact.
When normal saline was injected, while the needle injection catheter contacted the endocardium without needle protrusion, ICE showed intracavity microbubbles in all cases (Fig. 3C) . The injection site appeared as a focus of new bright myocardial echo enhancement on the ICE image (Fig. 3D) . In all cases, multiple discrete regions of brightness were apparent. When the volume of injectate was increased from 0.5 to 2.0 ml, in 0.5-ml increments, in the same injection site, the area of myocardial echo enhancement was proportional to the volume of injectate (Fig.  4) . It is noteworthy that the observed site of myocardial brightening persisted for at least 20 min, which was the total time required for completion of all the endomyocardial injections in a pig, although myocardial enhancement was slowly fading out.
Validation of localizing the injection site
In protocol I, there were 64 injections with Evans blue into eight pigs. In protocol II, there were 42 injections of a mixture of pCK-CAT and India ink into seven pigs. Discrete dye-staining sites located in left ventricular myocardial areas were identified at necropsy, in all 106 injection sites. These sites were compared with the injection sites indicated prospectively in vivo on the endocardial map. In protocol I, ICE predicted the injection sites correctly in 56 sites of 64 injections (87.5%). By segmental analysis, there was near complete agreement between ICE and postmortem study in septal (90% match), inferior (100% match), lateral (100% match) and apical (100% match) walls. However, there was some disagreement in anterior (73% match) and posterior (70% match) walls. In protocol II, ICE predicted the injection sites correctly in 42 sites of 42 injections (100%).
CAT gene expression study
In ELISA analysis, we identified significant CAT expression at 40 sites out of 42 injections (95.2%), where endomyocardial India ink staining was observed in the postmortem study. Of the two sites with failed gene expression, one was the site where intracavitary microbubbles were observed by ICE during plasmid DNA injection, even though there was no leakage when the test saline was injected into the endomyocardium. The average amount of CAT expressed in the gene injection sites was 65,600 6 10,930 pg/g wet tissue, and that in areas remote from the injection sites, as control sites, was 34 6 59 pg/g wet tissue. These levels differ significantly (p , 0.001).
b-Galactosidase gene expression study
Grossly, the blue staining of b-galactosidase or fluorescence of microspheres had a small-patchy or streaky appearance, and was located endocardially on the cross-sectioned surface of myocardium ( Fig. 5A and B) . They were detected in 20 of total 24 injections. Failure to observe staining or fluorescence may have been due to technical difficulties to find injection sites in 3-to 5-mm thickened cross-sections.
Histochemical analysis of sections from heart injected with the pCN-LacZ DNA clearly demonstrated b-galactosidase activity within cardiac myocytes that were easily identified by their myofibrillar architecture ( Fig. 5C and D) . Between 10 and 50 positively staining myocytes were seen around the injection site. Because there were often noncontiguous, quite focal and patchy, it was difficult to quantitate accurately the percentage of cells expressing b-galactosidase activity in a given heart. However, it is clear that the uptake of DNA and/or its expression is a relatively low-frequency event and only a small fraction of cardiac myocytes, that is, less than 1%, expressed the idence of an acute inflammatory response along the track of the needle and in most cases fibrosis along the needle track was observed. The degree of gene expression or inflammation along the needle track was not significantly different between two groups of pigs injected with DNA mixed with or without fluorescent microspheres, respectively.
Safety study
No pig died during the procedure. The procedure caused no significant changes in heart rate, mean blood pressure, and ejection fraction during the procedure.
There were no significant arrhythmias, such as atrioventricular block, atrial fibrillation, atrial tachycardia, ventricular fibrillation, or sustained ventricular tachycardia (.3 sec) during the procedure. Isolated or consecutive ventricular premature beats (fewer than five beats) were noted, intermittently, during the manipulation of the tip of the injection catheter, during needle advancement into the endomyocardium, and during the injection of injectate.
In one case of protocol I, and one case of protocol II, minimal pericardial effusions (no echo-free pericardial space during diastole) developed during the procedure, without progression. Regional wall motion abnormality was evaluated visually, and ICE showed no evidence of global or regional wall motion abnormalities, immediately after the procedure. ICE did not find any mural thrombus or intramural hematoma, immediately after the procedure. From color Doppler evaluation, ICE showed no significant mitral and aortic regurgitation before or after the procedure.
At postmortem examination, neither pericardial hematoma nor cardiac muscle rupture was found in any of the protocols. However, a small amount of serosanguinous bluish pericardial effusion was found in one case in protocol I, which showed minimal pericardial effusion on ICE imaging. There was no pericardial effusion in protocol II. Mural thrombus, chordal rupture, and intramural hematoma were not found in any of the protocols.
DISCUSSION
We have shown that percutaneous transendomyocardial gene delivery is a feasible and safe procedure under the guidance of ICE, complemented with fluoroscopy. In this study, a small-diameter, high-frequency ICE catheter facilitated high-quality image monitoring during PEGT, because the imaging catheter could be maintained in position for the entire procedure, without interruption of interventional procedures. With this image monitoring system, we have demonstrated how safely and effectively PEGT can be performed, avoiding any adverse effects on the heart. Real-time ICE monitoring enhances PEGT by guiding needle injection, monitoring leakage, ensuring delivery of injectate into the myocardium, and instantly diagnosing cardiac complications, thereby leading to successful gene transfer.
ICE as a complementary guiding tool for percutaneous transendomyocardial gene transfer
Studies of porcine hearts have reported that myocardial injection can be safely accomplished percutaneously, using an electromechanical mapping system Kornowski et al., 2000) or fluoroscopy-guided system (Sanborn et al., 2000; Gwon et al., 2001 ). However, it may not provide complete information in complicated situations that may occur during the procedure, such as regional wall motion change, leakage of injectate, or the development of valvular regurgitation or pericardial effusion. Therefore, a more accurate monitoring system is required during the whole procedure, for safe and effective gene delivery in clinical practice.
The recently developed, catheter-based ICE transducer has the features of small diameter and steerability, and combines two-dimensional, M-mode and Doppler capabilities for anatomical, functional, and hemodynamic evaluation (Bruce et al., 1999) . Our study shows that ICE is a useful monitoring tool, complementing either fluoroscopy or electromechanical mapping for PEGT, because it provides precise anatomical information in real time, without interruption of the procedure, or any attenuation of image by other tissues.
Utility of ICE for guiding needle injection
Imaging with ICE during injection ensured that DNA was delivered into the myocardium. Leakage of injectate generated microbubbles, which could easily be detected by ICE imaging. Even though we did not use agitated injectate mixed with air, injection through a long 27-gauge needle, which needs modest force to advance the plunger of the syringe, might generate a fine "mist" of microbubbles by rapid injection (Ziskin et al., 1972; Meltzer et al., 1980) . Therefore, the operator can determine immediately whether the injection should be interrupted and a new, satisfactory needle position found. ICE can provide further assurance, in real time, that injectate is delivered into the myocardium because the site of the injectate appears as a focus of myocardial echodensity enhancement on ICE imaging. This is not due to the development of intramural hematoma. No intramural hematoma was observed in any immediate or delayed postmortem study in either protocol. The phenomenon could be related to the change in the ultrasonic character of the myocardial tissue by the injectate itself, or by the microbubbles generated. In our previous study, when we injected a mixture of radiocontrast dye and plasmid DNA into the myocardium, venous structures were frequently observed on fluoroscopic imaging, sometimes accompanied by drainage into the coronary sinus (Gwon et al., 2001) . Therefore, indetectable microbubbles alone cannot guarantee that injectate is delivered completely into the myocardium. Focal myocardial enhancement without microbubbles will indicate the full delivery of angiogenic factor or genes into the myocardium. This issue of delivery with precision is particularly critical in the case of naked DNA, because the efficiency of transfection of naked DNA is low and successful phenotypic modulation is heavily dependent on secretion of gene product from a small number of transfected myocytes . Moreover, in the case of viral vectors, spill into systemic circulation could induce unwanted gene expression outside the heart. Enhancement of the myocardial echo after injection persisted for at least 20 min. Therefore, the possibility of making a duplicative injection at the same site during the procedure is minimized.
When a prespecified injection site was targeted, ICE study gave good results, as indicated by postmortem assessment of those sites based on dye staining. However, targeting the injection site by ICE was not always successful in the anterior and posterior walls, because the anatomical landmark for ICE was not prominent in these segments. Improvement should be possible with more experience, and with the complementary use of biplane fluoroscopy instead of the single-plane fluoroscopy used in this study or an electromechanical mapping system.
Gene expression study
For the gene expression study, both the CAT gene and the b-galactosidase gene were chosen because they can be quantitated easily, and because of the ease of histochemical detection of transfection efficiency and types of cells transfected (bgalactosidase gene). Even though the level of CAT gene expression in injected sites was significantly high compared with the level in noninjected areas, transfection efficiency using bgalactosidase plasmid DNA was low and confined to a small area around the injection site. Only 10 to 50 scattered blue cells were noted around the injection site. Our results are consistent with previous findings, that is, when naked DNA was injected into rat heart, 98% of the activity of reporter genes was restricted to a small area around the injection site and the transfection efficiency was low, corresponding to only , 2000 cells in the entire heart (Kitis et al., 1993) . However, genes encoding a secreted protein such as vascular endothelial cell growth factor (VEGF) may overcome the handicap of inefficient transfection by a paracrine effect, causing secretion of sufficient protein to achieve local levels that may be physiologically meaningful. Furthermore, our ICE-guided system could be used generally to deliver genes to the heart by means of high-efficiency vectors such as adenovirus or adeno-associated virus.
Complication of the procedure
One of the most worrisome complications associated with the percutaneous myocardial gene injection technique is left ventricular perforation with the injection needle. In this study, online ICE imaging instantly detected two cases of minimal pericardial effusion (one in protocol I, and one in protocol II) and during the procedure. However, the procedure could proceed because there was no further increase in pericardial effu- sion, vital signs were stable, and cardiac tamponade physiology did not develop, as assessed by Doppler examination. We speculate that pericardial effusion occurred because of extravasation of injectate, with a relatively large volume (7-11 ml/heart) injected into the pericardial space rather than the hemopericardium. During postmortem examination, serosanguinous bluish pericardial effusion, rather than blood, was found in the case with pericardial effusion in protocol I, and there was no pericardial effusion, blood, hematoma or adhesion in protocol II or III. This work confirms the findings of previous studies, that arrhythmia or wall motion abnormality is not a problem with direct myocardial gene injection (Losordo et al., 1998; Vale et al., 1999) . Nevertheless, careful electrocardiogram and ICE monitoring of patients with ischemia or poor cardiac function, who are at high risk of malignant arrhythmia or heart failure, is indicated. Finally, chordal injury by catheter, and inadequate injection into papillary muscle, could be avoided by ICE guidance, and new developments of valvular regurgitation could be monitored with Doppler examination of ICE.
Limitations of the study
In spite of its ability to evaluate wall motion change in real time, the ICE study could not give us complete information about myocardial viability. Therefore, it would be helpful if stress or contrast echocardiography (Nagueh et al., 1997) , and an electromechanical mapping system (Kornowski et al., 1998; Fuchs et al., 1999) , could be combined with ICE. This study was also limited to application in the normal heart, not the ischemic heart. However, we believe that the information obtained from real-time ICE imaging could be used even more profitably during PEGT procedures in patients with chronic ischemia. In patients with chronic ischemia who have thinned and scarred myocardia, ICE would be useful for on-site evaluation of wall thickness. The relative value of our technique compared with sole fluoroscopy-guided, or electromechanical mapping, catheter-based intramyocardial injection and a comparison between the efficacy of percutaneous and surgical techniques, both guided by the ICE system, have not been examined and need further studies. Finally, it should be emphasized that our experiment has no obvious clinical implication for therapeutic myocardial angiogenesis as yet, since no relevant angiogenic gene was used in this study.
CONCLUSIONS
This study demonstrates that an ICE transducer with high image resolution can provide continuous monitoring, without interruption to the procedure. Online ICE monitoring is safe and useful during percutaneous intramyocardial gene transfer, for guiding needle injection to distinct sites, monitoring leakage, ensuring delivery of injectate into the myocardium, and instantly diagnosing cardiac complications, thereby leading to successful gene transfer. ICE has obvious clinical implications in percutaneous endomyocardial gene injection, in clinical cardiology.
